Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Adamant Global Biotech

+ Add to Watchlist

ADGLBIA:SW

3,620.47 CHF 14.68 0.40%

As of 11:14:00 ET on 05/21/2015.

Snapshot for Adamant Global Biotech (ADGLBIA)

Year To Date: +10.53% 3-Month: +5.84% 3-Year: +41.98% 52-Week Range: 2,392.63 - 4,015.18
1-Month: -3.35% 1-Year: +59.84% 5-Year: - Beta vs SMI: 1.27

Mutual Fund Chart for ADGLBIA

No chart data available.
  • ADGLBIA:SW 3,620.47
  • 1M
  • 1Y
Interactive ADGLBIA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ADGLBIA

Adamant Global Biotech is an open-end fund incorporated in Switzerland. The objective of the Fund is to obtain long-term capital growth with active management. The Fund invests on a global basis in the shares of companies in the biotech sector.

Inception Date: 10-15-2010 Telephone: +41 800 850 050
Managers: JOHN MANIERI
Web Site: www.zkb.ch/fonds

Fundamentals for ADGLBIA

NAV (on 2015-05-21) 3,620.47
Assets (M) (on 2015-05-21) 162.23
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for ADGLBIA

Dividend Type Omitted
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for ADGLBIA

Front Load 2.50
Back Load 1.00
Current Mgmt Fee 1.81
Redemption Fee 1.00
12b1 Fee -
Expense Ratio 1.84

Top Fund Holdings for ADGLBIA

Filing Date: 01/31/2015
Name Position Value % of Total
Celgene Corp 134,000 14,690,843 9.900%
Biogen Inc 40,000 14,321,866 9.651%
Gilead Sciences Inc 140,000 13,502,838 9.099%
Amgen Inc 95,000 13,308,247 8.968%
Alexion Pharmaceuticals Inc 52,000 8,766,678 5.908%
Regeneron Pharmaceuticals Inc 21,000 8,050,309 5.425%
Vertex Pharmaceuticals Inc 73,000 7,397,404 4.985%
Illumina Inc 40,000 7,183,382 4.841%
Medivation Inc 65,000 6,507,790 4.386%
Mylan NV 120,000 5,868,079 3.954%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil